Neuro-Bio’s CEO, Baroness Susan Greenfield, will lead the inaugural session at the upcoming WeMind International Forum in Barcelona. Susan...

Researchers at Neuro-Bio Ltd in collaboration with an international team of clinicians and neuroscientists have published a new perspective...

Aptamer Group plc, the developer of novel Optimer binders, announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology...

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, and Neuro-Bio,...

Neuro-Bio is ready to move to human trials using a radical approach that targets neurodegeneration long before it can...

British scientists believe they may have discovered the first effective treatment for dementia. Researchers at Neuro-Bio say their potential remedy...

Baroness Susan Greenfield is, among other things, a scientist, author, broadcaster, member of the House of Lords and the...

We are pleased to announce that Neuro-Bio is the latest company to join the Kairos portfolio, following our investment...